ArticleAdvanced healthcare materials2021

Tumor-Targeted Inhibition of Monocarboxylate Transporter 1 Improves T-Cell Immunotherapy of Solid Tumors.

Tongyi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.